Mark Sturdevant, MD

Mark Sturdevant, MD, is a transplant surgeon, focusing on liver transplantation. Dr. Sturdevant has extensive experience in living donor and split liver transplantation, an advanced surgical technique that involves dividing a single donor liver to treat two separate recipients at the same time. His expertise also includes resection of abdominal tumors involving the hepatic hilum (a region of the liver) and liver resections requiring vascular reconstructions. He also performs kidney and pancreas transplants.

Dr. Sturdevant is the new program director and division head of the Scripps Center for Organ and Cell Transplantation. In this role, he leads the multidisciplinary activities of the Scripps organ transplant program, including living and deceased kidney, liver and pancreas transplantation. His myriad responsibilities include overseeing quality assessment and performance improvement programs; maintaining compliance with transplantation regulatory bodies; ensuring appropriate department staffing and training; and driving improved access to transplantation. 

Previously, Dr. Sturdevant served as a transplant surgeon and held academic faculty positions at two of the world’s preeminent living donor liver transplant (LDLT) institutions: the University of Pittsburgh Medical Center in Pittsburgh, Pa. and the King Faisal Specialist Hospital and Research Center in Riyadh, Saudi Arabia. With this international experience, he co-chaired the surgical workgroup at the 2021 American Transplantation Society LDLT Consensus Conference to develop guidelines advancing innovation and surgical training in LDLT.

He also served as a transplant surgeon at the University of Washington Medical Center in Seattle, Washington. There, he collaborated with heart transplant colleagues to perform the world’s first series of dual liver-heart transplantations involving “domino liver transplantation,” a procedure where a patient receives a new liver and then donates their own removed liver to another recipient as a usable graft. 

Dr. Sturdevant’s research has been widely disseminated through peer-reviewed medical journals, book chapters and conference presentations. At the 2025 annual meeting of the American Hepato-Pancreato-Biliary Association, he provided insights into how to establish and develop an LDLT and split liver program.